Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

66.64
Delayed Data
As of Sep 23
 -0.17 / -0.25%
Today’s Change
26.80
Today|||52-Week Range
70.92
+47.68%
Year-to-Date
Ligand Inks CNS License Agreement with Seelos Therapeutics
Sep 23 / Zacks.com - Paid Partner Content
Dicerna Pharmaceuticals (DRNA) Worth a Look: Stock Up 6%
Sep 22 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: ANI Pharmaceuticals, Stoneridge, Cooper-Standard Holdi...
Sep 23 / Zacks.com - Paid Partner Content
Regeneron, Teva Collaborate to Develop Chronic Pain Drug
Sep 21 / Zacks.com - Paid Partner Content
7 Stocks Near 52-Week Highs Worth Betting On
Sep 22 / Zacks.com - Paid Partner Content
Amgen (AMGN) Repatha Meets Endpoints in Phase III Study
Sep 21 / Zacks.com - Paid Partner Content
The Medicines Co. to Get BARDA Funding for Infection Drugs
Sep 22 / Zacks.com - Paid Partner Content
Puma (PBYI) Neratinib's NDA Accepted for Review, Stock Up
Sep 21 / Zacks.com - Paid Partner Content
AstraZeneca Withdraws Cediranib Marketing Application in EU
Sep 22 / Zacks.com - Paid Partner Content
Adamas (ADMS) Parkinson's Disease Drug Positive in Phase III
Sep 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close66.81
Today’s open66.34
Day’s range65.64 - 66.98
Volume120,428
Average volume (3 months)227,021
Market cap$767.3M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-49.03%
Earnings growth (this year)+51.29%
Earnings growth (next 5 years)+15.40%
Revenue growth (last year)+36.36%
P/E ratio78.4
Price/Sales6.83
Price/Book4.79

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...-0.51-1.75%
AMAGAMAG Pharmaceuticals...+0.08+0.33%
RTRXRetrophin Inc-0.70-3.01%
MNTAMomenta Pharmaceutic...-0.22-1.82%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$1.09
Annual revenue (last year)$76.3M
Annual profit (last year)$15.3M
Net profit margin20.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur S. Przybyl
Vice President-
Operations
James G. Marken
Corporate headquarters
Baudette, Minnesota

Forecasts

Search for Jobs